{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:24:09Z","timestamp":1767918249068,"version":"3.49.0"},"reference-count":23,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2007,11,7]],"date-time":"2007-11-07T00:00:00Z","timestamp":1194393600000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Birth Defects Research"],"published-print":{"date-parts":[[2007,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>BACKGROUND:<\/jats:title><jats:p>The prevalence of anencephaly (AN) and spina bifida (SB) was declining long before fortification of enriched grains in the U.S. with folic acid. We examined whether changes in these defects surrounding fortification could be distinguished from preexisting trends.<\/jats:p><\/jats:sec><jats:sec><jats:title>METHODS:<\/jats:title><jats:p>We used data from the Metropolitan Atlanta Congenital Defects Program to identify three ascertainment periods: Period 1 (1968\u20131981), prenatal diagnoses rarely made; Period 2 (1981\u20131993), prenatal diagnoses made but not ascertained; Period 3 (1994\u20132003), prenatal diagnoses ascertained. We compared the annual percent change (APC) in AN and SB for each period using Poisson regression, then compared prevalences during each period for categories of pregnancy outcome, sex, race, gravidity, and maternal age.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS:<\/jats:title><jats:p>The prevalence of AN (<jats:italic>N<\/jats:italic> = 434) and SB (<jats:italic>N<\/jats:italic> = 663) declined during 1968\u20132003. The APCs in Periods 1, 2, and 3, respectively, were \u22126.9%, \u22122.9%, and \u22126.8% for AN, and \u22127.1%, \u22127.0%, and \u22126.2% for SB; 95% confidence intervals around the APCs for Periods 2 and 3 overlapped for both defects. Prevalence ratios (PRs) for females relative to males decreased for AN (2.3 in Period 1; 1.2 in Period 3); PRs for whites relative to blacks or African Americans decreased for both AN (2.7 in Period 1; 1.2 in Period 3) and SB (2.5 in Period 1; 1.1 in Period 3).<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSIONS:<\/jats:title><jats:p>Our analysis suggests that changes in AN and SB surrounding folic acid fortification (Period 3) could be part of preexisting trends. This must be considered when evaluating prevention efforts. Birth Defects Research (Part A) 79:730\u2013736, 2007. \u00a9 2007 Wiley\u2010Liss, Inc.<\/jats:p><\/jats:sec>","DOI":"10.1002\/bdra.20401","type":"journal-article","created":{"date-parts":[[2007,11,7]],"date-time":"2007-11-07T23:46:30Z","timestamp":1194479190000},"page":"730-736","source":"Crossref","is-referenced-by-count":27,"title":["Interpreting changes in the epidemiology of anencephaly and spina bifida following folic acid fortification of the U.S. grain supply in the setting of long\u2010term trends, Atlanta, Georgia, 1968\u20132003"],"prefix":"10.1002","volume":"79","author":[{"given":"Lilah M.","family":"Besser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura J.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet D.","family":"Cragan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,11,7]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2005-1364"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a008653"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/bdra.20210"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/bdra.20294"},{"issue":"4","key":"e_1_2_6_6_1","first-page":"1","article-title":"Surveillance for anencephaly and spina bifida and the impact of prenatal diagnosis\u2014United States 1985\u20131994","volume":"44","author":"Centers for Disease Control and Prevention","year":"1995","journal-title":"MMWR"},{"key":"e_1_2_6_7_1","first-page":"808","article-title":"Folate status in women of childbearing age, by race\/ethnicity\u2014United States, 1999\u20132000","volume":"51","author":"Centers for Disease Control and Prevention","year":"2002","journal-title":"MMWR"},{"key":"e_1_2_6_8_1","first-page":"1301","article-title":"Improved national prevalence estimates for 18 selected major birth defects\u2014United States, 1999\u20132001","volume":"54","author":"Centers for Disease Control and Prevention","year":"2006","journal-title":"MMWR"},{"key":"e_1_2_6_9_1","first-page":"65","article-title":"Reporting birth defects surveillance data 1968\u20132003","volume":"79","author":"Correa A","year":"2007","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199212243272602"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/tera.1420440508"},{"key":"e_1_2_6_12_1","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780192618849.001.0001","volume-title":"Epidemiology and control of neural tube defects","author":"Elwood JM","year":"1992"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-8749.1991.tb05089.x"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.23.2981"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a113335"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)90133-A"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.96.5.880"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/tera.1420250309"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.87.9.1467"},{"key":"e_1_2_6_20_1","first-page":"8781","article-title":"Food standards: amendment of standards of identity for enriched grain products to require addition of folic acid","volume":"61","author":"U.S. Food and Drug Administration","year":"1996","journal-title":"Fed Regist"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/tera.10060"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2005-0592"},{"key":"e_1_2_6_23_1","volume-title":"Neural tube defects: from origin to treatment","author":"Wyszynski DF","year":"2006"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.1992.02160190089028"}],"container-title":["Birth Defects Research Part A: Clinical and Molecular Teratology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fbdra.20401","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/bdra.20401","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T04:55:01Z","timestamp":1724734501000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/bdra.20401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":23,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["10.1002\/bdra.20401"],"URL":"https:\/\/doi.org\/10.1002\/bdra.20401","archive":["Portico"],"relation":{},"ISSN":["1542-0752","1542-0760"],"issn-type":[{"value":"1542-0752","type":"print"},{"value":"1542-0760","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}